Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127019041 | 12701904 | 1 | I | 20160617 | 0 | 20160830 | 20160830 | DIR | 62.00 | YR | F | N | 0.00000 | 20160829 | N | PH | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127019041 | 12701904 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | Subcutaneous | D | D | 0 | 44 | UG | TIW |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127019041 | 12701904 | 1 | Multiple sclerosis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127019041 | 12701904 | Blindness | |
127019041 | 12701904 | Inflammation | |
127019041 | 12701904 | Influenza | |
127019041 | 12701904 | Multiple sclerosis relapse | |
127019041 | 12701904 | Optic nerve disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
127019041 | 12701904 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127019041 | 12701904 | 1 | 20070101 | 20160829 | 0 |